Peptide contraception in women: Inhibition of ovulation by chronic intranasal LRH agonist therapy
- 28 February 1985
- journal article
- Published by Elsevier in Contraception
- Vol. 31 (2) , 111-118
- https://doi.org/10.1016/0010-7824(85)90023-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Endometrial Patterns in Women on Chronic Luteinizing Hormone-Releasing Hormone Agonist Treatment for ContraceptionFertility and Sterility, 1981
- Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?Contraception, 1981
- Recent Approaches to Fertility Control Based on Derivatives of LH-RHPublished by Elsevier ,1981
- LH‐RH Agonists and AntagonistsInternational Journal of Gynecology & Obstetrics, 1980
- Ovulation inhibition by daily I.M. Administration of a highly active LH-RH analog (D-ser(TBU)6-LH-RH-(1–9)-nonapeptide-ethylamide)Contraception, 1980
- INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENTThe Lancet, 1979
- Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonistContraception, 1979